Thursday, November 19, 2026
Financial News
Nov 12, 2026, 1:00 PMPharmaceuticals

Drugmakers Bet Billions on Vaccines as Moderna and Merck Data Show Promise

Moderna and Merck’s experimental cancer-vaccine data, plus research linking shingles vaccination to delayed dementia, support continued vaccine investment.

A vaccine vial lighthouse illuminates cancer cells and a neural web amid a political storm.
Listen to this briefingAudio briefing

Summary

MarketWatch reported on November 12, 2026, that major drug companies are committing billions of dollars to vaccines despite the political environment. The extract identifies Moderna and Merck as examples but provides no investment breakdown, timeline or policy specifics.

The support cited is promising data for Moderna and Merck’s experimental cancer vaccine, alongside research suggesting shingles vaccination can delay dementia. These findings strengthen the case for vaccine research, but the limited feed omits trial results, development milestones and details about the shingles vaccine.

Positives

  • Promising data support continued development of Moderna and Merck’s experimental cancer vaccine.
  • Research suggests shingles vaccination can delay dementia, indicating a potential benefit beyond preventing shingles.
  • Billions of dollars are being committed to vaccines by major drug companies despite the political environment.

Risks & concerns

  • Moderna and Merck’s cancer vaccine remains experimental, and the extract provides no development timeline.
  • The limited feed includes no trial size, efficacy percentage, safety findings or statistical results for the cancer vaccine.
  • The source does not identify the shingles vaccine, its manufacturer or the strength of the dementia research.
  • The political environment is presented as an obstacle, but the extract provides no policy or regulatory details.
Primary sourceMarketWatch.com - Top Storieshttps://www.marketwatch.com/story/the-worlds-most-sophisticated-drug-companies-are-putting-billions-into-vaccines-despite-the-political-environment-8dcbf276?mod=mw_rss_topstories
Read full article
Editorial note: Financial News summarizes and analyzes third-party reporting and public filings. The source link is the authoritative document. This page does not reproduce the full source text and is not investment advice.

More From The Wire

A medicine injector casts a dark shadow across an eye, symbolizing possible GLP-1-related vision loss. PharmaceuticalsNov 9

Ozempic, Zepbound and GLP-1 Drugs Linked to Possible Vision Loss Risk

A capsule-shaped buoy lifts a sagging financial line, reflecting Wegovy's support for Novo Nordisk's outlook. PharmaceuticalsNov 4

Novo Nordisk Stock Jumps as Wegovy Pill Uptake Lifts Guidance

A balance scale weighs a shrinking mass against red thorns, symbolizing greater weight loss and more side effects. PharmaceuticalsSep 30

Eli Lilly’s Zepbound and Amylin Combination Delivers Up to 23% Weight Loss